Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.7 USD | +0.59% | +2.41% | +20.57% |
May. 02 | ATyr Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 02 | Earnings Flash (LIFE) ATYR PHARMA Reports Q1 Revenue $235,000 | MT |
Evolution of the average Target Price on aTyr Pharma, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering aTyr Pharma, Inc.
RBC Capital Markets | |
Piper Sandler | |
Oppenheimer | |
Roth MKM | |
HC Wainwright | |
Roth Capital Partners | |
JonesTrading Institutional Services | |
Laidlaw & Co. |
EPS Revisions
- Stock Market
- Equities
- LIFE Stock
- Consensus aTyr Pharma, Inc.